2 Stable Stocks Every Investor Should Be Watching Now

NYSE: JNJ | Johnson & Johnson News, Ratings, and Charts

JNJ – The stock market is witnessing heightened volatility due to the multi-decade high inflation and the Fed’s rate hikes. Given the uncertainties ahead, fundamentally sound stocks Johnson & Johnson (JNJ) and Novartis (NVS), which seem relatively stable, might be ideal additions to your watchlist. Keep reading….

Despite sky-high prices and consecutive rate hikes, the economy seems resilient. The labor market remains tight, with a less than 4% unemployment rate. Moreover, the third quarter GDP increased by 2.6% at an annualized pace, better than expected. This has somewhat eased recession worries.

In addition, experts remain hopeful of prices coming down. Fundstrat’s head of research, Tom Lee, opines that inflation indicators, like housing prices, are witnessing a decline, and the Fed could soon soften its pace of rate hikes. Moreover, according to Morgan Stanley’s Mike Wilson, investors could see the bear market to end as soon as early next year.

However, the market remains volatile amid uncertainties. So, we think fundamentally solid stocks Johnson & Johnson (JNJ) and Novartis AG (NVS), which are relatively stable, should be on your watchlist now.

Johnson & Johnson (JNJ)

JNJ and its subsidiaries research, develop, manufacture, and sell various products in the healthcare field worldwide. The company operates through three segments: Consumer Health; Pharmaceutical; and Medical Devices.

On September 20, 2022, On September 20, JNJ opened its San Francisco Bay Campus, a cutting-edge Research and Development (R&D) center in the Bay Area, one of the most well-known global hubs for innovation and entrepreneurship.

The facility connects essential scientific and technology resources by combining Janssen R&D, Johnson & Johnson Innovation, and Johnson & Johnson Technology and is expected to contribute significantly to the field of medicine.

JNJ’s total sales increased 1.9% year-over-year to $23.79 billion for the third quarter ended 2022. Moreover, its net earnings came in at $4.46 billion, up 21.6% year-over-year. Also, its EPS came in at $1.68, up 22.6% year-over-year.

JNJ’s revenue is expected to increase by 2.8% year-over-year to $97.83 billion in 2023. Its EPS is expected to grow 3.2% year-over-year to $10.37 in 2023. It surpassed EPS estimates in all four trailing quarters. Over the past year, the stock has gained 5.2% to close the last trading session at $172.31. It has a beta of 0.42.

JNJ’s strong fundamentals are reflected in its POWR Ratings. The stock’s overall A rating indicates a Strong Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

JNJ has an A grade for Stability and a B for Quality. In the Medical – Pharmaceuticals industry, it is ranked #4 out of 162 stocks. Click here for the additional POWR Ratings for Value, Sentiment, Growth, and Momentum for JNJ.

Novartis AG (NVS)

Headquartered in Basel, Switzerland, NVS researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments: Innovative Medicines; and Sandoz.

On October 25, 2022, Vas Narasimhan, NVS’ M.D. and CEO, said, “Looking ahead, we are confident in delivering growth and margin expansion through our new focused “pure-play” Innovative Medicines strategy, underpinned by our five core T.A.s, technology platforms, priority geographies, and a deep, value-oriented pipeline.”

NVS’ total current liabilities came in at $28.16 billion for the period ended September 30, 2022, compared to $30.21 billion for the period ended December 31, 2021. Its total liabilities came in at $57.57 billion, compared to $63.97 billion for the same period.

NVS’ revenue is expected to increase marginally yearly to $52.48 billion in 2023. Its EPS is expected to grow 6.6% year-over-year to $6.45 in 2023. It surpassed EPS estimates in three of four trailing quarters. Over the past month has gained 6.6% to close the last trading session at $79.54. It has a beta of 0.50.  

NVS’ POWR Ratings reflect this promising outlook. It has an overall A rating, equating to a Strong Buy in our POWR Ratings system. It has an A grade for Stability and a B for Value and Quality. It is ranked #13 in the same industry.

We have also rated NVS for Growth, Sentiment, and Momentum. Get all NVS ratings here.

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year


JNJ shares were trading at $174.59 per share on Friday afternoon, up $2.28 (+1.32%). Year-to-date, JNJ has gained 4.07%, versus a -17.17% rise in the benchmark S&P 500 index during the same period.


About the Author: Rashmi Kumari


Rashmi is passionate about capital markets, wealth management, and financial regulatory issues, which led her to pursue a career as an investment analyst. With a master's degree in commerce, she aspires to make complex financial matters understandable for individual investors and help them make appropriate investment decisions. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
JNJGet RatingGet RatingGet Rating
NVSGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Does Trump Change Stock Market Outlook?

The rally of the S&P 500 (SPY) after the election gives a sense that investors are happy that Trump was elected. But perhaps there is more to this story than meets the eye. That’s why Steve Reitmeister shares his updated market outlook taking into account the pros and cons of Trumps proposed new policies. This comes with a preview of his top 11 stocks to buy now.

3 Streaming Stocks Benefiting from Cord-Cutting Trends

As streaming continues to dominate the digital entertainment landscape, the global streaming market presents a lucrative investment opportunity. So, it could be ideal to invest in fundamentally solid streaming stocks Netflix (NFLX), Walt Disney (DIS), and Roku (ROKU). Read further...

3 Gold Stocks to Buy as Safe-Haven Demand Grows

Gold is a stable investment now due to its role as a safe-haven asset during economic uncertainty, rising demand, industrial use, and growth, bolstered by central bank purchases and interest rate cuts. Therefore, investors should consider investing in top gold stocks such as Newmont (NEM), Barrick Gold (GOLD), and Agnico Eagle Mines (AEM). Read more...

3 AI Stocks Transforming Industries and Driving Future Growth

With rapid digitalization, rapid adoption, and development, as well as surging demand, the AI market is on the rise. Amid this backdrop, investors could buy fundamentally solid AI stocks NVIDIA Corporation (NVDA), Microsoft (MSFT), and Meta Platforms (META) poised for substantial gains. Continue reading...

Updated Stock Market Expectations

The S&P 500 (SPY) has already reached an impressive goal of hitting 6,000. Yet you can see how much shares are struggling now up against this resistance. Steve Reitmeister shares his views on what comes next for the market and his top 10 stocks to stay on the right side of the action.

Read More Stories

More Johnson & Johnson (JNJ) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All JNJ News